Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis.
Headaches in multiple sclerosis: Cross-sectional study of a multiethnic population.
Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis.
Meta-analysis of adverse events in recent randomized clinical trials for dimethil fumarate, glatiramer acetate and teriflunomide for the treatment of relapsing forms of multiple sclerosis.
Neuroprotective effects of resident microglia following acute brain injury.
US and EU regulatory authorities accept oral BG-12 marketing applications for review
Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.
A study comparing the effectiveness and safety of teriflunomide and interferon beta-1a in patients with relapsing multiple sclerosis (TENERE)
A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.
Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID).
Randomized trial of oral teriflunomide for relapsing multiple sclerosis.
Clinical Characteristics of Pediatric-Onset and Adult-Onset Multiple Sclerosis in Hispanic Americans.
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis.
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis.
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis.
Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study.
Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
An older dog with newer tricks: Predicting efficacy of IFN-β treatment for multiple sclerosis.
Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis.
Birth Outcomes in Newborns Fathered by Men with Multiple Sclerosis Exposed to Disease-Modifying Drugs.
The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF gamma-globulins.
Firategrast
Anti-Human Herpesvirus 6A/B IgG Correlates with Relapses and Progression in Multiple Sclerosis.
The employment concerns of Americans with multiple sclerosis: Perspectives from a national sample.

Pages